[Latest information on the treatment of uterine cervical cancer]

Gan To Kagaku Ryoho. 2002 Aug;29(8):1377-82.
[Article in Japanese]

Abstract

We investigated the role of hemoglobin level in chemoradiation therapy for patients with advanced cervical cancer by reviewing the literature for current therapeutic information. We found that anemia during chemoradiation therapy is an important physiological factor in determining the long-term prognosis of patients with advanced cervical cancer.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Cell Hypoxia
  • Clinical Trials as Topic
  • Erythropoietin / therapeutic use
  • Female
  • Hemoglobins / analysis*
  • Humans
  • Prognosis
  • Recombinant Proteins
  • Uterine Cervical Neoplasms / blood
  • Uterine Cervical Neoplasms / drug therapy*
  • Uterine Cervical Neoplasms / radiotherapy*

Substances

  • Hemoglobins
  • Recombinant Proteins
  • Erythropoietin